Cosmos Health Reports Robust Sales of Proprietary Brands on Amazon UK
Cosmos Health Reports 160% Increase In 2024 YTD Sales Of Proprietary Brands On Amazon UK, Reaching $596K Compared To $230K In 2023
Cosmos Health Gets Over $500,000 in UK Initial Orders for Antimicrobial Wash
Cosmos Health Receives Initial Orders Exceeding $500,000 For C-Scrub In The UK; Future Orders Booked At Accelerated Pace With Strong Profitability Anticipated Due To High Profit Margins
Cosmos Health Enters Development Phase for CCDL24, an Innovative Multitargeting Product for Gastrointestinal Disorders, With a Market Size Valued at Over $37.5 Billion
Cosmos Health Releases 2024-2027 Updated Guidance; Projects Revenue of $155.8M and Adjusted EBITDA of $29.4M Annually by 2027, Driven by Strategic Focus on High-Margin Segments